Altasciences is a contract research organisation (CRO) and contract development and manufacturing organisation (CDMO) offering fully integrated solutions for early-phase drug development.

With over 25 years of experience, Altasciences provides comprehensive support to pharmaceutical and biotechnology companies, streamlining the pathway from discovery to proof of concept. The company’s services span preclinical research, clinical trials, bioanalysis, and manufacturing, ensuring a seamless transition between each phase. By integrating these capabilities under one organisation, Altasciences helps clients reduce timelines and improve decision-making throughout the drug development process.

Key Products and Services:

Preclinical Research – GLP and non-GLP toxicology, pharmacology, and safety assessments.
Clinical Trials – First-in-human (FIH) through proof-of-concept studies, including Phase I and II trials.
Bioanalysis – Comprehensive bioanalytical testing, including small and large molecule analysis.
Manufacturing and Formulation – Early-stage drug manufacturing, formulation development, and analytical services.
Regulatory Support – Expertise in regulatory strategy, dossier preparation, and compliance.
Data Services – Biostatistics, data management, and reporting solutions.

Altasciences is committed to reducing the complexity of drug development by providing an agile, flexible, and fully integrated approach. With a focus on collaboration and efficiency, the company helps its partners bring innovative therapies to patients faster and more effectively.